Acelyrin (SLRN) Q2 2023 Earnings Call Transcript
SLRN earnings call for the period ending June 30, 2023.
Source: fool.com
Ken Lock News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Ken Lock. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Ken Lock Today - Breaking & Trending Today
Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) Q4 2022 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by. And welcome to Arcutis Biotherapeutics, Inc. Fourth Quarter 2022 Earnings Conference Call.
Source: insidermonkey.com
Bucks chaplain and barber making impact with Evolve Church community center
CBS 58 is your local source for the Milwaukee news, Milwaukee weather, and Milwaukee sports.
Source: cbs58.com
Arcutis Launches ZORYVE (Roflumilast) Cream 0.3% in the United States for Treatment of Plaque Psoriasis in Individuals Age 12 and Older
10.08.2022 - Next-generation topical PDE4 inhibitor for adults and adolescents with plaque psoriasis now available in pharmacies nationwideEffective, safe, and very well-tolerated steroid-free cream that rapidly clear plaques and reduces itch Arcutis committed ... Seite 1
Source: wallstreet-online.de
With 'bold experiment' in drug pricing, Arcutis aims to stand out in plaque psoriasis
The FDA approved Arcutis Biotherapeutics drug Zoryve, a topical treatment for plaque psoriasis. With the decision, the company will proceed with a pricing strategy it believes will speed up insurance coverage and patient adoption of the new treatment for the chronic inflammatory skin disorder.
Source: medcitynews.com